The  	The  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
apelin  	apelin  	 NN	B-NP
in  	in  	 IN	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	I-NP
cardiovascular  	cardiovascular  	 JJ	I-NP
diseases  	diseases  	 NNS	I-NP
and  	and  	 CC	O
metabolic  	metabolic  	 JJ	B-NP
disorders  	disorders  	 NNS	I-NP
Apelin  	Apelin  	 NNP	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
recently  	recently  	 RB	O
discovered  	discovered  	 VBN	O
biologically  	biologically  	 JJ	O
active  	active  	 JJ	O
peptide  	peptide  	 JJ	O
present  	present  	 NN	O
in  	in  	 IN	O
several  	several  	 JJ	O
isoforms  	isoforms  	 NN	B-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
agonists  	agonists  	 VBN	O
for  	for  	 IN	O
orphan  	orphan  	 JJ	B-NP
receptor  	receptor  	 NN	I-NP
APJ 	APJ 	 NNP	I-NP
.  	.  	 .	O
Apelin  	Apelin  	 NNP	B-NP
and  	and  	 CC	O
APJ  	APJ  	 NNP	B-NP
receptor  	receptor  	 NN	I-NP
were  	were  	 VBD	O
found  	found  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
central  	central  	 JJ	O
nervous  	nervous  	 JJ	O
system  	system  	 NN	O
and  	and  	 CC	O
in  	in  	 IN	O
different  	different  	 JJ	O
peripheral  	peripheral  	 JJ	B-NP
tissues 	tissues 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
cardiovascular  	cardiovascular  	 JJ	B-NP
system  	system  	 NN	I-NP
the  	the  	 DT	O
peptide  	peptide  	 NN	B-NP
is  	is  	 VBZ	O
present  	present  	 JJ	O
both  	both  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
heart  	heart  	 NN	O
and  	and  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
endothelium  	endothelium  	 NN	B-NP
and  	and  	 CC	O
smooth  	smooth  	 JJ	O
muscles  	muscles  	 JJ	O
cells  	cells  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
vascular  	vascular  	 JJ	B-NP
wall 	wall 	 NN	I-NP
.  	.  	 .	O
Acting  	Acting  	 VBG	O
on  	on  	 IN	O
cardiomyocytes  	cardiomyocytes  	 JJ	B-NP
apelin  	apelin  	 NNS	I-NP
exerts  	exerts  	 VBP	O
positive  	positive  	 JJ	B-NP
inotropic  	inotropic  	 JJ	I-NP
effect 	effect 	 NN	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
the  	the  	 DT	O
endothelium  	endothelium  	 NN	B-NP
it  	it  	 PRP	O
releases  	releases  	 VBZ	O
nitric  	nitric  	 JJ	B-NP
oxide 	oxide 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
mediates  	mediates  	 VBD	O
its  	its  	 PRP$	O
vasodilatory  	vasodilatory  	 JJ	B-NP
action 	action 	 NN	I-NP
,  	,  	 ,	O
while  	while  	 IN	O
acting  	acting  	 VBG	O
directly  	directly  	 RB	O
on  	on  	 IN	O
smooth  	smooth  	 JJ	O
muscles  	muscles  	 JJ	O
cells  	cells  	 NNS	O
it  	it  	 PRP	O
causes  	causes  	 VBZ	O
vasoconstriction 	vasoconstriction 	 VBN	O
.  	.  	 .	O
Apelin  	Apelin  	 JJ	O
interacts  	interacts  	 NN	O
with  	with  	 IN	O
other  	other  	 JJ	O
compounds  	compounds  	 NNS	O
regulating  	regulating  	 VBG	B-NP
blood  	blood  	 NN	I-NP
pressure 	pressure 	 NN	I-NP
;  	;  	 :	O
for  	for  	 IN	O
instance  	instance  	 NN	O
with  	with  	 IN	O
angiotensin  	angiotensin  	 JJ	O
II 	II 	 NNP	O
,  	,  	 ,	O
vasopressin 	vasopressin 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
with  	with  	 IN	O
the  	the  	 DT	O
sympathetic  	sympathetic  	 JJ	O
nervous  	nervous  	 JJ	O
system 	system 	 NN	O
.  	.  	 .	O
Special  	Special  	 JJ	B-NP
attention  	attention  	 NN	I-NP
is  	is  	 VBZ	O
focused  	focused  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
of  	of  	 IN	O
positive  	positive  	 JJ	B-NP
role  	role  	 NN	I-NP
of  	of  	 IN	I-NP
apelin  	apelin  	 NN	I-NP
in  	in  	 IN	O
hypertension 	hypertension 	 NN	O
,  	,  	 ,	O
initial  	initial  	 JJ	O
stages  	stages  	 NNS	O
of  	of  	 IN	O
heart  	heart  	 NN	B-NP
failure  	failure  	 NN	I-NP
and  	and  	 CC	O
ischaemic  	ischaemic  	 JJ	B-NP
heart  	heart  	 NN	I-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
Synthesis  	Synthesis  	 NNP	O
of  	of  	 IN	O
apelin  	apelin  	 NN	B-NP
in  	in  	 IN	O
adipocytes  	adipocytes  	 JJ	B-NP
permits  	permits  	 NNS	I-NP
to  	to  	 TO	O
include  	include  	 VB	O
this  	this  	 DT	O
peptide  	peptide  	 NN	B-NP
among  	among  	 IN	O
adipokines 	adipokines 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
adipose  	adipose  	 JJ	O
tissue  	tissue  	 NN	O
its  	its  	 PRP$	O
production  	production  	 NN	O
is  	is  	 VBZ	O
increased  	increased  	 VBN	O
in  	in  	 IN	O
obesity  	obesity  	 NN	B-NP
and  	and  	 CC	O
by  	by  	 IN	O
insulin 	insulin 	 NN	O
.  	.  	 .	O
It  	It  	 PRP	O
appears  	appears  	 VBZ	O
that  	that  	 DT	O
apelin  	apelin  	 NN	B-NP
may  	may  	 MD	O
play  	play  	 VB	O
essential  	essential  	 JJ	B-NP
role  	role  	 NN	I-NP
in  	in  	 IN	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	O
insulin-resistant  	insulin-resistant  	 JJ	O
obesity 	obesity 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
type  	type  	 NN	O
2  	2  	 CD	O
diabetes  	diabetes  	 NN	B-NP
apelin  	apelin  	 NN	I-NP
improves  	improves  	 VBZ	O
glucose  	glucose  	 JJ	B-NP
tolerance  	tolerance  	 NN	I-NP
in  	in  	 IN	O
initial  	initial  	 JJ	O
stages  	stages  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
illness 	illness 	 NN	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
further  	further  	 RB	O
experimental  	experimental  	 JJ	O
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
required  	required  	 VBN	O
for  	for  	 IN	O
full  	full  	 JJ	O
evaluation  	evaluation  	 NN	O
of  	of  	 IN	O
significance  	significance  	 NN	B-NP
of  	of  	 IN	O
positive  	positive  	 JJ	O
and  	and  	 CC	O
negative  	negative  	 JJ	B-NP
aspects  	aspects  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
apelin  	apelin  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
cardiovascular  	cardiovascular  	 JJ	O
and  	and  	 CC	O
metabolic  	metabolic  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
